focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNeptune-Calculus Income & Growth Regulatory News (NEP)

  • There is currently no data for NEP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Yearly Report

23 Aug 2012 14:33

RNS Number : 6845K
Neptune-Calculus Income &Growth VCT
23 August 2012
 



CORPORATE POLICY AND PERFORMANCE SUMMARY

Objective

Neptune-Calculus Income and Growth VCT is a tax efficient listed company which has the objective of generating long term capital growth and tax free dividends for investors. The Company is managed as a VCT in order that shareholders may benefit from the tax reliefs available.

The Company's investment policy is to invest approximately 75 per cent of the Company's funds in a diversified portfolio of holdings in qualifying investments whether unquoted or traded on AIM. Investments are made selectively across a diverse range of sectors in companies which have the potential to generate growth and enhance their value. The Company does not invest in start-up and seed capital situations. The qualifying investments are managed by Calculus Capital Limited, and the balance of the Company's investments can be invested in a combination of Neptune income funds and a portfolio of similar income generating UK listed shares and money market instruments.

Performance summary

Six months to

30 June 2012

Deficit per Ordinary Share

(0.9)p

Net asset value per Ordinary Share

56.2 p

Cumulative dividends paid per Ordinary Share

18.5 p

Proposed interim dividend

1.0 p

As at

31 July 2012*

Net asset value per Ordinary Share

56.6 p

*Being the latest practicable date prior to publication and including net revenue after 30 June 2012.

 

CHAIRMAN'S STATEMENT

I present your Company's results for the six months ended 30 June 2012. Net assets per Ordinary Share on 30 June 2012 were 56.2 pence compared with 58.9 pence as at 31 December 2011. The major part of the movement is attributable to the dividend of 2.0 pence per Ordinary Share paid in June. The dividend payment is outlined in the section below, and took the total cumulative dividends paid on the Ordinary Shares since inception to 18.5 pence.

Our qualifying investments, which include both unquoted and AIM companies, are managed by Calculus Capital Limited. Over the period under review, the overall value of the quoted companies rose on a like-for-like basis by approximately 4.5 per cent, although the AIM market itself, was down by over 2.7 per cent. The value of the unquoted portfolio fell by 6.5 per cent on a like-for-like basis during the period because the Company's holding in Heritage House Media Limited was written down to nil.

In March 2012, RMS Group Holdings Limited redeemed its preference shares. The proceeds of £200,000 were reinvested in April as part of the Company's investment in Participate Sport Limited. The investment was made to support the acquisition of Human Race Limited, thereby creating the UK's largest and most diverse mass participation sports company. The combined group, which adopted the name Human Race Group Limited, owns and delivers over 55 events to over 100,000 participants of all abilities and ages.

In May 2012, Triage Holdings Limited redeemed just under £93,000 of the Company's holding of preference shares.

At 30 June 2012, our non-qualifying investments comprised holdings in the Neptune Income Fund and Neptune Quarterly Income Fund as well as £68,000 held in cash funds. These investments are managed by the Board to ensure that the Company has the required amount of liquidity available to it at any point in time. £200,000 of the Neptune Funds were sold during the period. The Neptune Funds, which have a bias towards income generating large cap stocks, showed a small increase in value over the period. Since the period end we have reduced further our holdings of the Neptune Funds and increased our holding of liquidity funds.

A more detailed analysis of qualifying investment performance can be found in the Investment Managers' Review following this statement.

Dividends

The 2011 final dividend of 2.0 pence per Ordinary Share was paid in June following shareholder approval at the AGM. In line with our policy of maximizing tax-free dividends to shareholders, the Directors are pleased to declare an interim dividend of 1 penny per Ordinary Share, payable on 17 October 2012 to shareholders on the register on 21 September 2012.

Share Buybacks

In order to return further cash to shareholders, the Board has exercised its powers to buy back shares during the period. In the six months to 30 June 2012, the Company repurchased a total 283,163 Ordinary Shares for cancellation at an average price of 52.5 pence per Ordinary Share. As at 30 June 2012 there were 11,351,880 Ordinary Shares in issue.

 

Outlook

Official figures for the UK economy indicate that the outlook remains uncertain and Europe continues to be a concern. Smaller companies can be a good lead indicator of underlying economic activity and the performance of those in our portfolio indicates that the economy may fare better over the rest of 2012 than is generally predicted.

Philip Stephens

 Chairman

23 August 2012

 

INVESTMENT MANAGER'S REVIEW (QUALIFYING INVESTMENTS)

Calculus Capital advises the Company in respect of qualifying investments made by the Company.

Portfolio developments

At 30 June 2012 the portfolio of qualifying investments comprised 16 companies, made up of both AIM quoted and unquoted stocks. The Company continues to meet the requirements for approved VCT status.

During the period the Company made no further quoted investments. We are pleased to report that the quoted portfolio went up in value despite the AIM market itself falling by 2.7 per cent.

EpiStem Holdings plc ("EpiStem") continues to show year on year growth in revenues and earnings, and in March 2012, announced a three year biomarker collaboration with GlaxoSmithKline in the field of fibrosis research. Also in March, EpiStem signed a sales and marketing agreement with Xcelris Limited, one of India's leading Diagnostics testing companies, for its rapid molecular test for tuberculosis ("TB"). India has the largest number of TB sufferers in the world with two million new patients developing TB every year.

Pressure Technologies plc develops high pressure equipment for the oil and gas, biogas and defence industries. The company is now seeing improved activity from the oil and gas industry and also expects to see continued growth in its engineered products division following the acquisitions of Al-Met Limited and Hydratron Limited. Both Al Met (which manufactures engineered alloys for high pressure valves), and Hydratron (which manufacturers pumps and hydraulic control panels), supply products that can be used on existing rigs as well as new ones, and have profited from increased industry investment on existing rigs.

At 30 June 2012, the value of the unquoted companies was £3,504,683. The portfolio fell by 6.5 per cent over the period on a like-for-like basis due to the investment in Heritage House Media being written down to nil in April after the company appointed administrators following withdrawal of its overdraft facility at short notice.

The Company invested £400,000 in Human Race Group Limited in April ("Human Race"), formerly Participate Sport Limited. Human Race is now the UK's largest and most diverse mass participation sports events company. The portfolio of events includes the Toshiba Windsor Triathlon, Cycletta, the Eton Triathlon Super Sprints, Festival of Sport Cornwall, Wiggle Dragon Ride, Etape Cymru, Off Road Winter Series, the Speedo Open Water Swimming Series and a partnership with the British 10k Run powered by Nike+. The group's objective is to be a leader in the ownership and delivery of mass participation sports events internationally. The mass participation industry has grown strongly over the past decade and its rapid growth has been relatively unaffected by the recent economic recession. The team behind Human Race is the team behind Quintus Group Limited ("Quintus"), a previous investment by the Company, which owned and managed a number of sporting events. Quintus was sold to IMG, the world's largest sports rights company in 2007.

Terrain Energy Limited ("Terrain") continues to make good progress, and the fair value of the investment has increased to reflect this. In February, Terrain acquired a 12.5 per cent equity interest in the Burton on the Wolds licence in the East Midlands from Egdon Resources and Celtique Energie in a 2:1 farm in. Terrain currently has interests in six petroleum licences: Keddington, Kirklington, Dukes Wood, Kelham Hills, Burton on the Wolds and Larne in Northern Ireland in which Terrain has a 10 per cent interest. The main prospect is a conventional gas play thought to be a geological extension of the Morecambe Bay gas field. A 2D seismic survey of 399 line kilometres has been completed and a number of structural leads have been identified. Terrain also has a 10 per cent interest in a Nautical Petroleum operated application in the 27th licensing round.

 

Developments since the period end

There have not been any significant developments in the qualifying portfolio since the period end.

Outlook

The outlook for the UK economy remains uncertain. Overall, we are encouraged by the resilience of the companies in both the quoted and unquoted portfolios and believe they are well placed to benefit as the economy recovers.

John Glencross

Calculus Capital Limited

 23 August 2012

 

INVESTMENT PORTFOLIO

The ten largest holdings by value are included below: As at 30 June 2012

Cost

Valuation

Percentageof portfolio

£

£

%

AIM investments (quoted equity)

EpiStem Holdings plc*

251,261

788,435

12.5%

Pressure Technologies plc

200,402

206,976

3.3%

Other AIM investments*

1,942,037

69,929

1.1%

Unquoted equity investments

Terrain Energy Limited

413,633

557,113

8.8%

Waterfall Services Limited

50,129

530,464

8.4%

Lime Technology Limited

213,958

459,625

7.3%

RMS Group Holdings Limited

92,339

430,155

6.8%

Human Race Group Limited

100,000

100,000

1.6%

Other unquoted equity investments

970,242

35,000

0.6%

Triage Holdings Limited*

50,589

0

0.0%

Unquoted preference shares

Triage Holdings Limited preference shares ‡

265,013

334,711

5.3%

Unquoted bonds

Waterfall Services Limited loan stock

333,333

333,333

5.3%

Human Race Group Limited

300,000

300,000

4.8%

Lime Technology Limited loan stock

200,000

200,000

3.2%

Other unquoted bonds

620,436

120,000

1.9%

Triage Holdings Limited loan stock

74,280

74,280

1.2%

Terrain Energy Limited loan stock

75,000

75,000

1.2%

Non-qualifying equity investments and loan stock

-334,878

-86,654

-1.4%

Total qualifying investments

5,817,774

4,528,367

71.8%

Quoted funds

Neptune Quarterly Income Fund Income Units

851,658

834,050

13.2%

The Neptune Income Fund Income A Class

833,013

791,134

12.5%

Unquoted funds

SWIP Global Liquidity Fund

42,000

42,000

0.7%

Fidelity Sterling Fund distributing shares class A

26,155

26,155

0.4%

GS Sterling Liquid Reserves

378

378

0.0%

Non-qualifying equity investments and loan stock

334,878

86,654

1.4%

Total non-qualifying investments

2,088,082

1,780,371

28.2%

Total investments

7,905,856

6,308,738

100%

 

‡ The valuation of Triage Holdings Limited preference shares includes a redemption premium which is non-qualifying. This cost £nil and is valued at £69,698.

* The valuations of certain investments include small non-qualifying investments. These cost £20,260 and are valued at £16,955.

UNAUDITED INCOME STATEMENT

for the six months to 30 June 2012

 

Six months to 30 June 2012

Six months to30 June 2011

Year to

31 December 2011*

Revenue

Capital

Total

Revenue

Capital

Total

Revenue

Capital

Total

Note

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

Losses on investments at fair value

-

(83)

(83)

-

(362)

(362)

-

(604)

(604)

Investment income

94

-

94

96

-

96

223

-

223

Investment management fee

(11)

(34)

(45)

(9)

(27)

(36)

(21)

(62)

(83)

Other expenses

(66)

-

(66)

(90)

-

(90)

(158)

-

(158)

Return/(deficit) on ordinary activities before finance charges and taxation

17

(117)

(100)

(3)

(389)

(392)

44

(666)

(622)

Finance charges

-

-

-

-

-

-

-

-

-

Taxation on ordinary activities

-

-

-

-

-

-

-

-

-

Return/(deficit) attributable to Ordinary

shareholders

17

(117)

(100)

(3)

(389)

(392)

44

(666)

(622)

Return/(deficit) per Ordinary Share

3

0.15p

(1.02)p

(0.87)p

(0.02)p

(3.24)p

(3.26)p

0.37p

(5.63)p

(5.26)p

 

*These figures are audited.

The total column of this statement is the profit and loss account of the Company. The revenue and capital columns are provided as supplementary information in accordance with the AIC SORP.

All revenue and capital items in the above statement derive from continuing operations. No operations were acquired or discontinued in the period.

There is no statement of recognised gains and losses as there were no other gains and losses.

The accompanying notes are an integral part of this statement.

UNAUDITED RECONCILIATION OF MOVEMENTS IN SHAREHOLDERS' FUNDS

for the six months to 30 June 2012

 

Share capital

Share premium

Capital Special redemption reserve reserve

Capitalreserve

Revenue reserve

Total

£'000

£'000

£'000

£'000

£'000

£'000

£'000

For the period 1 January 2012 to 30 June 2012

1 January 2012

1,163

631

9,255

77

(4,319)

45

6,852

Cancellation of own shares

(28)

-

(150)

28

-

-

(150)

Net deficit after taxation for the period

-

-

-

-

(117)

17

(100)

Equity dividends paid

-

-

(182)

-

-

(45)

(227)

30 June 2012

1,135

631

8,923

105

(4,436)

17

6,375

For the period 1 January 2011

to 30 June 2011

1 January 2011

1,230

631

10,039

10

(3,653)

165

8,422

Cancellation of own shares

(67)

-

(401)

67

-

-

(401)

Net deficit after taxation for the period

-

-

-

-

(389)

(3)

(392)

Equity dividends paid

-

-

(267)

-

-

(163)

(430)

30 June 2011

1,163

631

9,371

77

(4,042)

(1)

7,199

For the year 1 January 2011

to 31 December 2011*

1 January 2011

1,230

631

10,039

10

(3,653)

165

8,422

Cancellation of own shares

(67)

-

(401)

67

-

-

(401)

Net (deficit)/return after taxation for the year

-

-

-

-

(666)

44

(622)

Equity dividends paid

-

-

(383)

-

-

(164)

(547)

31 December 2011

1,163

631

9,255

77

(4,319)

45

6,852

 

*These figures are audited.

The accompanying notes are an integral part of this statement.

 

UNAUDITED BALANCE SHEET

as at 30 June 2012

 

30 June

2012

30 June

2011

31 December 2011

Note

£'000

£'000

£'000

Fixed Assets

Investments at fair value through profit or loss

6,309

6,594

6,504

Current Assets

Debtors

46

354

41

Cash at bank

115

287

377

161

641

418

Creditors: Amounts falling due within one year

Creditors

(95)

(36)

(70)

Net Current Assets

66

605

348

Net Assets

6,375

7,199

6,852

Represented by:

CALLED UP SHARE CAPITAL AND RESERVES

Share capital

1,135

1,163

1,163

Share premium

631

631

631

Special reserve

8,923

9,371

9,255

Capital redemption reserve

105

77

77

Capital reserve - investment holding loss

(2,839)

(1,285)

(1,505)

Capital reserve - other

(1,597)

(2,757)

(2,814)

Revenue reserve

17

(1)

45

Total Ordinary shareholders' funds

6,375

7,199

6,852

Net asset value per Ordinary Share

4

56.16p

61.87p

58.89p

*These figures are audited

The accompanying notes are an integral part of this statement

 

UNAUDITED CASH FLOW STATEMENT

for the six months to 30 June 2012

 

Six monthsto 30 June2012

Six monthsto 30 June2011

Year to 31 December

2011*

Note

£'000

£'000

£'000

Operating activities

Investment income received

92

115

247

Other income received

-

1

7

Investment management fees paid

(18)

(54)

(85)

Administration fees paid

(11)

(11)

(17)

Other cash payments

(60)

(89)

(130)

Net cash inflow/(outflow) from operating activities

5

3

(38)

22

Investing activities

Purchase of investments

(405)

(569)

(738)

Sale of investments

516

1,279

1,594

Net cash inflow from investing activities

111

710

856

Equity dividends paid

(227)

(431)

(547)

Financing

Shares bought back

(149)

(463)

(463)

Net cash outflow from financing

(149)

(463)

(463)

Decrease in cash

(262)

(222)

(132)

 

*These figures are audited.

The accompanying notes are an integral part of this statement.

 

CONDENSED NOTES TO THE ACCOUNTS

1 Nature of Financial Information

The unaudited half-yearly financial information does not constitute statutory financial statements as defined in Section 434 of the Companies Act 2006 and has not been reviewed nor audited by the auditors. This information has been prepared on the basis of the accounting policies used in the statutory financial statements of the Company for the year ended 31 December 2011. The statutory financial statements for the year ended 31 December 2011, which contained an unqualified auditors' report, have been lodged with the Registrar of Companies, did not include a reference to any matters to which the auditor drew attention by way of emphasis without qualifying the report and did not contain statements under Section 498(2) or (3) of the Companies Act 2006.

2 Dividends

The Directors have declared an interim dividend of 1 penny per Ordinary Share. This dividend is payable on 17 October 2012 to shareholders on the register on 21 September 2012.

3 Return per Ordinary Share

Six months to

30 June 2012

Six months to

30 June 2011

Year to

31 December 2011

Revenue

Capital

Total

Revenue

Capital

Total

Revenue

Capital

Total

pence

pence

pence

pence

pence

pence

pence

pence

pence

Ordinary Share

0.15

(1.02)

(0.87)

(0.02)

(3.24)

(3.26)

0.37

(5.63)

(5.26)

Revenue return per Ordinary Share is based on the net revenue return on ordinary activities attributable to the Ordinary Shares of £17,000 (30 June 2011: £3,000 deficit, 31 December 2011: £44,000 return) and on 11,476,347 (30 June 2011: 12,022,374, 31 December 2011: 11,827,117) Ordinary Shares, being the weighted average number of Ordinary Shares in issue during the period.

Capital return per Ordinary Share is based on the net capital deficit for the period of £117,000 (30 June 2011: £389,000, 31 December 2011: £666,000) and on 11,476,347 (30 June 2011: 12,022,374, 31 December 2011: 11,827,117) Ordinary Shares, being the weighted average number of Ordinary Shares in issue during the period.

Total return per Ordinary Share is based on the total deficit on ordinary activities attributable to the Ordinary Shares of £100,000 (30 June 2011: £392,000, 31 December 2011: £622,000) and on 11,476,347 (30 June 2011: 12,022,374, 31 December 2011: 11,827,117) Ordinary Shares, being the weighted average number of Ordinary Shares in issue during the period.

4 Net asset value per Ordinary Share

 

30 June 2012

30 June 2011

31 December 2011

pence

pence

pence

Ordinary Shares of 10p each

56.16

61.87

58.89

The basic net asset value per Ordinary Share is based on net assets (including current period revenue) of £6,375,000 (30 June 2011: £7,199,000, 31 December 2011: £6,852,000) and on 11,351,880 (30 June 2011: 11,635,043, 31 December 2011: 11,635,043) Ordinary Shares, being the number of Ordinary Shares in issue at the end of the period.

5 Reconciliation of net deficit before taxation to net cash inflow/(outflow) from operating

Activities

 

Six months to 30 June 2012

Six months to30 June 2011

Year to

31 December 2011

£'000

£'000

£'000

Net deficit before taxation

(100)

(392)

(622)

Net capital deficit

117

389

666

(Increase)/decrease in debtors

(5)

19

32

(Increase)/decrease in creditors

25

(26)

9

Investment management fee charged to capital

(34)

(26)

(62)

Income reinvested

-

(1)

(1)

Net cash inflow/(outflow) from operating activities

3

(38)

22

 

 

6 Related party transactions

The Company's qualifying investments are managed by Calculus Capital Limited. John Glencross, a Director of the Company, has an interest in Calculus Capital Limited. The amounts payable to the Managers are disclosed below:

Six months to 30 June 2012

Six months to 30 June 2011

Year to 31 December 2011

£'000

£'000

£'000

Investment management and

administration fees

56

47

105

Calculus Capital Limited receives annual fees from Terrain, Lime Technology Limited ("Lime") and Human Race for the provision of John Glencross as a Director, as well as annual monitoring fees. Calculus Capital also receives an annual monitoring fee from MicroEnergy Generation Services Limited ("MicroEnergy"). Other funds under the management or advice of Calculus Capital Limited have also invested in Terrain, Lime, MicroEnergy and Human Race. In the six months to 30 June 2012, the amount payable to Calculus Capital Limited which was attributable to the investment made by the Neptune-Calculus Income and Growth VCT plc was £3,014 (31 December 2011: £6,438) (including VAT) from Terrain, £3,731 (31 December 2011: £5,470) (including VAT) from Lime, £531 (31 December 2011: £927) (including VAT) from MicroEnergy and £987 (31 December 2011: nil) (including VAT) from Human Race.

 

 In the six months to 30 June 2012 Calculus Capital Limited received an arrangement fee of £12,000 (31 December 2011: nil) attributable to the Company's investment in Human Race. Total arrangement fees received as at 31 December 2011 were £17,526 attributable to the Company's investments in Heritage, Terrain, Lime and MicroEnergy.

STATEMENT OF DIRECTORS' RESPONSIBILITIES

The half-yearly financial report, which has not been audited or reviewed by auditors pursuant to the Auditing Practices Board Guidance on Review of Half-Yearly Financial Information is the responsibility of, and has been approved by, the Directors. The Directors confirm that to the best of their knowledge the half-yearly financial report, which has been prepared in accordance with the Disclosure and Transparency rules and in accordance with applicable accounting standards including the statement 'Half-yearly financial reports' issued by the UK Accounting Standards Board, gives a true and fair view of the assets, liabilities, financial position and the deficit of the Company as at 30 June 2012.

The Directors confirm that the Chairman's Statement, the Investment Managers' Reviews, and note 6, include a fair review of the information required by DTR 4.2.7R, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements and a description of the principal risks and uncertainties for the remaining six months of the financial year, and 4.2.8R of the Disclosure and Transparency Rules.

The Directors of Neptune-Calculus Income and Growth VCT plc are:

Philip Stephens

John Glencross

David Kempton

By order of the Board

Philip Stephens Chairman

23 August 2012

 

 

The half yearly report will shortly be posted to shareholders. Copies of the report will also be available from the Company's registered office at 104 Park Street, London, W1K 6NF or from the Qualifying Investment Manager's website at www.calculuscapital.com/neptunevct.aspx.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR PGURPRUPPGWW
Date   Source Headline
12th Sep 20174:05 pmRNSGM Statement
31st Aug 201712:46 pmRNSGM Statement
4th Aug 20175:57 pmRNSFurther re merger
4th Aug 20175:57 pmRNSMerger and Offer for subscription
10th Jul 20179:06 amRNSResult of AGM
19th Jun 20177:00 amRNSStatement re Recommended Proposals for Merger
19th Jun 20177:00 amRNSStatement re Recommended Proposals for Merger
7th Jun 20179:23 amRNSDirector Declaration
25th Apr 20175:39 pmRNSDirectorate Change
24th Mar 20171:08 pmRNSdividend record date
21st Mar 20176:28 pmRNS2016 results and Annual Financial Report
20th Oct 20165:10 pmRNSNet Asset Value(s)
19th Aug 20163:35 pmRNSHalf-year Report
17th May 20165:25 pmRNSResult of AGM
12th May 20163:46 pmRNSTotal Voting Rights
18th Mar 20163:54 pmRNSTransaction in Own Shares
15th Mar 20166:01 pmRNSAnnual Financial Report
26th Feb 20162:28 pmRNSDisclosure of Home Member State
18th Dec 201511:23 amRNSDirector/PDMR Shareholding
13th Aug 20155:01 pmRNSHalf Yearly Report
19th May 20156:13 pmRNSResult of AGM
20th Mar 20156:11 pmRNSFinal Results
30th Jan 201511:32 amRNSDividend Declaration
22nd Dec 20143:15 pmRNSDisposal
14th Aug 20146:27 pmRNSHalf Yearly Report
23rd May 201412:19 pmRNSAGM Statement
8th May 201412:38 pmRNSInterim Management Statement
4th Apr 20145:30 pmRNSAnnual Information Update
31st Mar 20143:45 pmRNSFinal Results
19th Nov 20133:12 pmRNSInterim Management Statement
15th Aug 201312:59 pmRNSHalf Yearly Report - Replacement
15th Aug 201311:31 amRNSHalf Yearly Report
7th Jun 20132:29 pmRNSTransaction in Own Shares and results of EBB
30th May 20133:54 pmRNSResult of Meeting
16th May 201312:43 pmRNSInterim Management Statement
10th May 20131:13 pmRNSAnnual Information Update
28th Mar 20133:47 pmRNSEBB Top up offer and Notice of meeting
27th Mar 20135:21 pmRNSFinal Results
16th Nov 20129:45 amRNSInterim Management Statement
23rd Aug 20122:33 pmRNSHalf Yearly Report
6th Jun 20123:33 pmRNSResult of AGM
6th Jun 20123:28 pmRNSTotal Voting Rights
16th May 20126:04 pmRNSInterim Management Statement
22nd Mar 20123:26 pmRNSAnnual Information Update
22nd Mar 20122:59 pmRNSTransaction in Own Shares and Annual Report
15th Mar 20124:33 pmRNSFinal Results
18th Nov 20114:54 pmRNSInterim Management Statement
17th Aug 20113:23 pmRNSHalf Yearly Report
17th Aug 20112:34 pmRNSTotal Voting Rights
21st Jun 20112:14 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.